Inhibition of respiratory viruses by nasally administered siRNA. - Wikidata - wikimedia - TriplyDB

Inhibition of respiratory viruses by nasally administered siRNA.

Inhibition of respiratory viruses by nasally administered siRNA.

http://www.wikidata.org/entity/Q47874231

about

Selective gene silencing by viral delivery of short hairpin RNA Ectopic expression of miR-126*, an intronic product of the vascular endothelial EGF-like 7 gene, regulates prostein translation and invasiveness of prostate cancer LNCaP cells Regression of murine lung tumors by the let-7 microRNA An intronic microRNA silences genes that are functionally antagonistic to its host gene Respiratory viruses other than influenza virus: impact and therapeutic advances The promises and pitfalls of RNA-interference-based therapeutics Therapeutic application of RNAi: is mRNA targeting finally ready for prime time?Whole blood gene expression in infants with respiratory syncytial virus bronchiolitis A single siRNA suppresses fatal encephalitis induced by two different flaviviruses.Epigenetics and miRNA emerge as key regulators of smooth muscle cell phenotype and function Induction of protective effector immunity to prevent pathogenesis caused by the respiratory syncytial virus. Implications on therapy and vaccine design Direct cytosolic delivery of siRNA using nanoparticle-stabilized nanocapsules Silencing Viral Infection RNAi-mediated gene silencing in tick synganglia: a proof of concept study Inhibition of Respiratory Syncytial Virus Infections With Morpholino Oligomers in Cell Cultures and in Mice siRNAs: potential therapeutic agents against hepatitis C virus Delivery of RNAi Therapeutics to the Airways-From Bench to Bedside Current prospects for RNA interference-based therapies A novel 5-lipoxygenase-activating protein inhibitor, AM679, reduces inflammation in the respiratory syncytial virus-infected mouse eye Aerosol Delivery of siRNA to the Lungs. Part 1: Rationale for Gene Delivery Systems Respiratory syncytial virus NS1 protein colocalizes with mitochondrial antiviral signaling protein MAVS following infection MicroRNA regulation of human protease genes essential for influenza virus replication Gene silencing: a therapeutic approach to combat influenza virus infections.Eukaryotic translation initiation factor 5A small interference RNA-liposome complexes reduce inflammation and increase survival in murine models of severe sepsis and acute lung injury A combinatorial library of lipid-like materials for delivery of RNAi therapeutics.Effective treatment of respiratory alphaherpesvirus infection using RNA interference.siRNA silencing of keratinocyte-specific GFP expression in a transgenic mouse skin model.Intracranial administration of P gene siRNA protects mice from lethal Chandipura virus encephalitis.Lipid-like materials for low-dose, in vivo gene silencing Pulmonary surfactant phosphatidylglycerol inhibits respiratory syncytial virus-induced inflammation and infection Attenuated Salmonella choleraesuis-mediated RNAi targeted to conserved regions against foot-and-mouth disease virus in guinea pigs and swine Non-viral siRNA delivery into the mouse retina in vivo.Drug delivery-mediated control of RNA immunostimulation Selection of potent non-toxic inhibitory sequences from a randomized HIV-1 specific lentiviral short hairpin RNA library.siRNA-based therapy ameliorates glomerulonephritis Pharmacologic advances in the treatment and prevention of respiratory syncytial virus.TransKingdom RNA interference: a bacterial approach to challenges in RNAi therapy and delivery.A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus.A status report on RNAi therapeutics.Double-stranded RNA induces sequence-specific antiviral silencing in addition to nonspecific immunity in a marine shrimp: convergence of RNA interference and innate immunity in the invertebrate antiviral response?

P2860

Q21245112-49527ABD-FC91-4141-8038-B58F8CFA5C98 Q24604908-BEC574D4-3E18-43F2-A774-41FE9D038808 Q24621218-BF10F998-CD32-4F3E-B4E3-62F29C5D73CF Q24653379-DFCC8175-7CF7-49C2-B389-791F2D92D4A9 Q24655957-5CD77A16-02CF-49BD-9D40-39737024B204 Q24657247-EBD9BE02-5508-4BC3-A310-C20E04CA53F8 Q24669624-885D7F74-AA0D-45EF-95EA-B7FEE6952A4C Q24679785-69CA3311-3B4F-4D0C-96FB-2B93302EE2AF Q25255046-97D85776-EB22-4FB5-88C8-2DA7AD28882A Q27006515-AF582B30-9067-45AE-80BF-6BFE08FB01BB Q27021304-B5609FD6-0C9D-493B-AFCC-B17693461D2C Q27339704-665D7906-AA92-4DF7-A922-0DF6FEE60883 Q27473399-83693F31-CA86-49CF-A8A3-85911D4A7989 Q27486085-B3496AAC-85CA-48F7-85DA-55DB446F0323 Q27490424-84474798-321B-4B4E-9CD0-C28A7AA8587E Q27694682-C4997DF0-3D33-4F9A-B424-36E75EC275C4 Q28067306-2F4CEDC1-967B-4E94-BCEE-8489B4F88E2E Q28235733-C801E469-CEEC-467E-BC1D-26B15E3DD28C Q28258798-B89679E9-C158-488A-8B51-7C508C14CC38 Q28392004-C0AA900E-6294-4984-BB16-CB17C9D12D0C Q28481271-50017CA4-C517-4D52-8DF6-2E2E44CEB916 Q28483683-E87ABD47-8619-42F8-B484-311472389E06 Q30370880-138EF30E-2E8D-497C-8F8C-B7B619266DA5 Q30436677-959AB24E-B1DE-4924-B244-F5D04473E70E Q33330928-CCD6AFA9-939D-4F08-8A5F-B584DA1626B3 Q33397374-E34A945F-F449-4126-BB82-06E5689F2CA4 Q33454280-8644EEE1-CF87-48A8-B62E-490F115742BD Q33523028-C8C5D614-9F93-4D74-91D2-9D19ADDDBF0E Q33583399-9E4B11A9-B9CE-4AAA-B6DA-3EB3E5FAA92F Q33591425-C1DE991F-9583-4E95-9AAF-AAE53B3AAD68 Q33676729-4D91647A-0CED-4787-BC8D-7C709640B7A3 Q33710058-6AFAE73D-ADB6-4D70-B49D-C2D09FBD3D1A Q33713938-8828CC9E-593A-412C-B111-1C3B222CCC6F Q33719287-FDE16BAA-FFCF-421C-8134-3CD7A30F74C9 Q33748522-70062204-0DA3-4712-B6D8-7E976914BDE0 Q33776507-7B673B55-BB7F-40FF-ACB0-26E7E348EC3F Q33848915-96C3763D-967B-4341-8E19-E5F7C6C86834 Q33928650-FFADBF1E-53CF-4697-81F0-CD290C3E1A64 Q34013891-4110EA0C-7F8C-4C21-8352-8C0C2A625DD0 Q34092648-AB433C0F-3F97-478A-9816-9F8A7E8093C6

P2860

Inhibition of respiratory viruses by nasally administered siRNA.

http://www.wikidata.org/entity/Q47874231

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

Inhibition of respiratory viruses by nasally administered siRNA.

@en

Inhibition of respiratory viruses by nasally administered siRNA.

@nl

type

label

Inhibition of respiratory viruses by nasally administered siRNA.

@en

Inhibition of respiratory viruses by nasally administered siRNA.

@nl

prefLabel

Inhibition of respiratory viruses by nasally administered siRNA.

@en

Inhibition of respiratory viruses by nasally administered siRNA.

@nl

P1433

Q47874231-1636A1E9-BBCB-41F8-835B-1A93D67B34B1

P1476

Q47874231-FDD31E75-5B82-4878-8482-8682957AE35A

P2093

Q47874231-5C91474E-5FAA-4CA1-BC1E-13701A6FC2B5

Q47874231-903B1836-025C-454C-9537-EEEB60F51FF3

Q47874231-94BE66B7-20A5-4117-B072-064250C8506E

Q47874231-F5E97996-5A99-42D6-A33C-4BEDA4286A89

P2860

Q47874231-0DF55045-0274-4B63-9AB1-A28319E0DDBB

Q47874231-100D3FA2-36D3-486F-BE7B-5F3AED581F15

Q47874231-153DAAC5-3531-41E5-8097-032EB048FB22

Q47874231-1C31C3DF-CCA6-4A0F-92FE-42D941EFF34D

Q47874231-1F6CD49A-809C-4F77-8CE7-4950307426B6

Q47874231-1FC6B1FC-0667-44A9-B066-9FBADF36CF69

Q47874231-2A1A0611-09A6-4F16-8D70-F6068A16EAEF

Q47874231-34EB438C-8EFD-4C37-9BEB-D12B91B19273

Q47874231-36D1CF88-62C9-41B4-9637-454F36AC385E

Q47874231-416D0BB2-4B97-4ACE-ADF5-AD240EE3BE65

P2888

Q47874231-75350D43-4401-4CC5-A359-93D3FFD097A9

P304

Q47874231-7635A65E-DC6B-4C6E-A61F-2780822AB60A

P31

Q47874231-63467C80-4F2E-4A9F-9095-11FEF4799C64

P356

Q47874231-39EBC10A-B539-4E1A-8B07-C5D5B84ABA23

P407

Q47874231-C6C0B3A6-25A7-4E2B-84A3-D997DAB9B41E

P433

Q47874231-7798631F-DD50-444E-9254-54C5FD5917CE

P478

Q47874231-ED14F860-1788-4535-8202-01D30CC82649

P577

Q47874231-A9A987FB-3F83-406B-80A8-606B8885DEAC

P5875

Q47874231-537E2EE3-80F3-4693-BA57-BB25FA01D0B0

P698

Q47874231-9D35341D-D07F-4F62-86DE-88C964E4A343

P356

P1433

Nature Medicine

P1476

Inhibition of respiratory viruses by nasally administered siRNA.

@en

P2093

Alla Musiyenko

http://www.w3.org/2001/XMLSchema#string

Olena Shulyayeva

http://www.w3.org/2001/XMLSchema#string

Sailen Barik

http://www.w3.org/2001/XMLSchema#string

Vira Bitko

http://www.w3.org/2001/XMLSchema#string

P2860

MicroRNAs in plants

Phenotypic silencing of cytoplasmic genes using sequence-specific double-stranded short interfering RNA and its application in the reverse genetics of wild type negative-strand RNA viruses

Asymmetry in the assembly of the RNAi enzyme complex

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

Rational siRNA design for RNA interference

Expression profiling reveals off-target gene regulation by RNAi

Activation of the interferon system by short-interfering RNAs

Profilin is required for optimal actin-dependent transcription of respiratory syncytial virus genome RNA.

Inducible expression of inflammatory chemokines in respiratory syncytial virus-infected mice: role of MIP-1alpha in lung pathology.

Recombinant bovine/human parainfluenza virus type 3 (B/HPIV3) expressing the respiratory syncytial virus (RSV) G and F proteins can be used to achieve simultaneous mucosal immunization against RSV and HPIV3.

P2888

P304

50-55

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NM1164

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2004-12-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8110321

http://www.w3.org/2001/XMLSchema#string

P698

15619632

http://www.w3.org/2001/XMLSchema#string